KEGG   Mustela lutreola (European mink): 131833891
Entry
131833891         CDS       T09578                                 
Symbol
CDKN1A
Name
(RefSeq) cyclin-dependent kinase inhibitor 1
  KO
K06625  cyclin-dependent kinase inhibitor 1A
Organism
mlk  Mustela lutreola (European mink)
Pathway
mlk01522  Endocrine resistance
mlk01524  Platinum drug resistance
mlk04012  ErbB signaling pathway
mlk04066  HIF-1 signaling pathway
mlk04068  FoxO signaling pathway
mlk04110  Cell cycle
mlk04115  p53 signaling pathway
mlk04151  PI3K-Akt signaling pathway
mlk04218  Cellular senescence
mlk04630  JAK-STAT signaling pathway
mlk04921  Oxytocin signaling pathway
mlk04928  Parathyroid hormone synthesis, secretion and action
mlk04934  Cushing syndrome
mlk05160  Hepatitis C
mlk05161  Hepatitis B
mlk05163  Human cytomegalovirus infection
mlk05165  Human papillomavirus infection
mlk05166  Human T-cell leukemia virus 1 infection
mlk05167  Kaposi sarcoma-associated herpesvirus infection
mlk05169  Epstein-Barr virus infection
mlk05200  Pathways in cancer
mlk05202  Transcriptional misregulation in cancer
mlk05203  Viral carcinogenesis
mlk05205  Proteoglycans in cancer
mlk05206  MicroRNAs in cancer
mlk05210  Colorectal cancer
mlk05211  Renal cell carcinoma
mlk05212  Pancreatic cancer
mlk05213  Endometrial cancer
mlk05214  Glioma
mlk05215  Prostate cancer
mlk05216  Thyroid cancer
mlk05217  Basal cell carcinoma
mlk05218  Melanoma
mlk05219  Bladder cancer
mlk05220  Chronic myeloid leukemia
mlk05222  Small cell lung cancer
mlk05223  Non-small cell lung cancer
mlk05224  Breast cancer
mlk05225  Hepatocellular carcinoma
mlk05226  Gastric cancer
Brite
KEGG Orthology (KO) [BR:mlk00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04012 ErbB signaling pathway
    131833891 (CDKN1A)
   04630 JAK-STAT signaling pathway
    131833891 (CDKN1A)
   04066 HIF-1 signaling pathway
    131833891 (CDKN1A)
   04068 FoxO signaling pathway
    131833891 (CDKN1A)
   04151 PI3K-Akt signaling pathway
    131833891 (CDKN1A)
 09140 Cellular Processes
  09143 Cell growth and death
   04110 Cell cycle
    131833891 (CDKN1A)
   04115 p53 signaling pathway
    131833891 (CDKN1A)
   04218 Cellular senescence
    131833891 (CDKN1A)
 09150 Organismal Systems
  09152 Endocrine system
   04921 Oxytocin signaling pathway
    131833891 (CDKN1A)
   04928 Parathyroid hormone synthesis, secretion and action
    131833891 (CDKN1A)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    131833891 (CDKN1A)
   05202 Transcriptional misregulation in cancer
    131833891 (CDKN1A)
   05206 MicroRNAs in cancer
    131833891 (CDKN1A)
   05205 Proteoglycans in cancer
    131833891 (CDKN1A)
   05203 Viral carcinogenesis
    131833891 (CDKN1A)
  09162 Cancer: specific types
   05210 Colorectal cancer
    131833891 (CDKN1A)
   05212 Pancreatic cancer
    131833891 (CDKN1A)
   05225 Hepatocellular carcinoma
    131833891 (CDKN1A)
   05226 Gastric cancer
    131833891 (CDKN1A)
   05214 Glioma
    131833891 (CDKN1A)
   05216 Thyroid cancer
    131833891 (CDKN1A)
   05220 Chronic myeloid leukemia
    131833891 (CDKN1A)
   05217 Basal cell carcinoma
    131833891 (CDKN1A)
   05218 Melanoma
    131833891 (CDKN1A)
   05211 Renal cell carcinoma
    131833891 (CDKN1A)
   05219 Bladder cancer
    131833891 (CDKN1A)
   05215 Prostate cancer
    131833891 (CDKN1A)
   05213 Endometrial cancer
    131833891 (CDKN1A)
   05224 Breast cancer
    131833891 (CDKN1A)
   05222 Small cell lung cancer
    131833891 (CDKN1A)
   05223 Non-small cell lung cancer
    131833891 (CDKN1A)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    131833891 (CDKN1A)
   05161 Hepatitis B
    131833891 (CDKN1A)
   05160 Hepatitis C
    131833891 (CDKN1A)
   05163 Human cytomegalovirus infection
    131833891 (CDKN1A)
   05167 Kaposi sarcoma-associated herpesvirus infection
    131833891 (CDKN1A)
   05169 Epstein-Barr virus infection
    131833891 (CDKN1A)
   05165 Human papillomavirus infection
    131833891 (CDKN1A)
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    131833891 (CDKN1A)
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    131833891 (CDKN1A)
   01522 Endocrine resistance
    131833891 (CDKN1A)
SSDB
Motif
Pfam: CDI
Other DBs
NCBI-GeneID: 131833891
NCBI-ProteinID: XP_059033766
LinkDB
Position
6:84270185..84278419
AA seq 164 aa
MEEPSREYRQIPRGSKACRRLFGPVDSEQLRRDCDALMAGCVQEAQERWNFDFITETPLE
GDFAWERVWGLGLPKLYLPTGSRGGRDDLGGGKWPSPSSGLLQGTAQEDHLDLSLSCTLM
PHSPERPEGSPGAPSTSQGRKRRQTSMTDFYHSKRRRIFSKRKP
NT seq 495 nt   +upstreamnt  +downstreamnt
atggaggagccatccagggaataccggcagatccctcggggcagcaaagcttgccgccgg
ctcttcggccccgtggacagtgagcagctgcggcgagactgtgacgcgctgatggccggc
tgcgtgcaggaggcccaggagcgatggaacttcgacttcatcactgagacgccgctggag
ggcgactttgcctgggagcgtgtgtggggcctgggcctgcccaagctctacctgcctacg
gggtcccgggggggccgggatgacctgggagggggcaagtggcccagcccttcgtctggc
ctgcttcaggggaccgctcaggaggaccatctggacctgtcgctctcctgcaccctcatg
cctcactcccctgagcggccagagggatccccaggggcgcctagcacctctcagggccgg
aaacggcggcagaccagcatgacagatttctatcactccaaacgccggcggatcttctcc
aagaggaagccctaa

DBGET integrated database retrieval system